Pranay Dey - Publications

Affiliations: 
2017- Molecular Functional Imaging Lab ACTREC- Tata Memorial Centre 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Joshi M, Dey P, De A. Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. Exploration of Targeted Anti-Tumor Therapy. 4: 1227-1248. PMID 38213543 DOI: 10.37349/etat.2023.00194  0.687
2023 Dey P, Gadewal N, De A. Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules. 242: 124765. PMID 37156315 DOI: 10.1016/j.ijbiomac.2023.124765  0.607
2022 Dey P, Joshi M, Mujawar A, Malhotra R, De A. Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordrecht). PMID 35834098 DOI: 10.1007/s13402-022-00693-6  0.466
2021 Goel S, Dey P, Dahiya D, Bhatia A. A not so worthless attempt to develop primary culture from breast FNAC/CNB samples! Tissue & Cell. 71: 101517. PMID 33677200 DOI: 10.1016/j.tice.2021.101517  0.375
2020 Mal A, Dey P, Hayes RM, McCarthy JV, Ray A, De A. Identification of Potential Phosphorylation in the Cytoplasmic Domain of Epithelial Cell Adhesion Molecule. Acs Omega. 5: 30808-30816. PMID 33324790 DOI: 10.1021/acsomega.0c02113  0.67
2020 Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Research and Treatment. PMID 33001337 DOI: 10.1007/s10549-020-05948-0  0.433
2020 Dey P, Wang A, Ziegler Y, Kim SH, El-Ashry D, Katzenellenbogen JA, Katzenellenbogen BS. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 12. PMID 32961773 DOI: 10.3390/Cancers12092677  0.46
2020 Dey P, Kundu A, Han SH, Kim KS, Park JH, Yoon S, Kim IS, Kim HS. Biological Evaluation of Oxindole Derivative as a Novel Anticancer Agent against Human Kidney Carcinoma Cells. Biomolecules. 10. PMID 32878322 DOI: 10.3390/biom10091260  0.318
2019 Dey P, Rathod M, De A. Targeting stem cells in the realm of drug-resistant breast cancer. Breast Cancer (Dove Medical Press). 11: 115-135. PMID 30881110 DOI: 10.2147/BCTT.S189224  0.733
Show low-probability matches.